Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Utrush** is an oral Ayurvedic polyherbal syrup marketed by Rantomo Lifesciences for female reproductive and urinary-health indications. Its declared botanical constituents are Ashoka (*Saraca indica*), Lodhra (*Symplocos racemosa*), Dhatkipushpa (*Woodfordia fruticosa*), Amla (*Emblica officinalis*), Vibheetaki (*Terminalia belerica*), Hareetaki (*Terminalia chebula*), Sunthi (*Zingiber officinale*), and Amrasthi (*Mangifera indica*). Rantomo promotes it for inflammatory processes involving the female reproductive system and urinary tract, irregular menstrual cycles, secondary amenorrhoea, female infertility, polycystic ovarian disease, and leucorrhoea. A specific molecular mechanism and regulatory approval documentation are not publicly described on the sponsor product page.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Utrush.